Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, September 23, 2015
Aesica, a global pharmaceutical contract development and manufacturing organization (CDMO), is pleased to announce its involvement in a renewable green initiative involving its UK, Cramlington site.
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced it has successfully introduced serialisation services and initiated commercial production of two anti-allergy product lines for the ...
read more
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced that its High Capacity Manufacturing Facility has been successfully validated for commercial production. $45m (USD) has been invested at...
read more
Tuesday, February 03, 2015
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), a division of Consort Medical plc, today announces it has received continuing FDA approvals for both its bulk manufacturing and packaging operations in ...
read more
Aesica has recruited a Technical Director to create global Lead Technical Centres for API development, drug product development and technology innovation.
read more
Wednesday, February 22, 2012
Global pharmaceutical manufacturer, Aesica, experienced significant growth in 2011, doubling both its turnover and its workforce and forming a number of long-term strategic partnerships with customers such as UCB and Noramco.
read more
Aesica, the global contract manufacturing organisation (CMO), announces a partnership with the University of Nottingham for the commercial development of alternative methods in amide bond synthesis. This latest partnership is already the Aesica ...
read more
Aesica Pharmaceuticals, a global pharmaceutical contract development and manufacturing organization (CDMO), provides a novel, modular based solution that provides pharmaceutical customers with a highly flexible, efficient and reliable technological ...
read more
Wednesday, April 16, 2014
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has led a consortium, also comprising Charnwood Technical Consulting, CatScI and Biocatalysts, which has successfully won a Technology Strategy Board grant...
read more
Friday, February 15, 2013
Aesica, the global contract manufacturing organisation (CMO), announces that it will be joining Britest in a collaboration where members share knowledge and risk in defining innovative solutions to key manufacturing challenges.
read more
Wednesday, October 14, 2015
Aesica has unveiled a new approach and business model that solves multiple supply chain challenges at once.
read more
Aesica Pharmaceuticals, the global pharmaceutical contract development and manufacturing organisation (CDMO), is adding additional services in its oral solids capability including a new roller compaction unit for dry granulation production in Zwickau...
read more
Aesica, the global contract development and manufacturing organisation (CDMO), today announced the appointment of two senior business development positions. Detlef Behrens has been appointed to the role of Vice President, Business Development, ...
read more
Aesica, the global contract development and manufacturing organisation (CDMO), has appointed Sven Thomas and David Ross as business development managers. Their appointment is the next phase in the company’s international drive to increase sales from ...
read more
Tuesday, February 18, 2014
Aesica, the global pharmaceutical contract development and manufacturing organisation (CDMO), has today announced the appointment of Ian Muir to the newly created position of Commercial Managing Director, effective from 24th February. The position is...
read more